Subject of the day
KVUE
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
FY 2023–2025 · 3 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $15.12B | -1.0% | |
| Gross profit | $8.79B | +112.0% | |
| Operating income | $2.51B | -3.1% | |
| Net income | $1.66B | +94.9% | |
| Cash from ops | $2.20B | -16.7% |
$19.20
▲ +0.22 (+1.2%)
| 52w hi | $20.71 |
|---|---|
| 52w lo | $13.46 |
| Vol | 10.40M |
| As of | Aug 13 |
Our score +0.09
| Short | +0.23 |
|---|---|
| Medium | +0.01 |
| Long | -0.01 |
computed 2026-08-13
Kenvue Inc.
Consumer Defensive · Household & Personal Products
| Market cap | $36.88B |
|---|---|
| Enterprise value | $43.96B |
| Trailing P/E | 22.59x |
| Forward P/E | 15.54x |
| EV / EBITDA | 12.63x |
| P / S (ttm) | 2.39x |
| Profit margin | 10.8% |
| Return on equity | 15.6% |
| Revenue growth | +3.0% |
| Earnings growth | +8.5% |
| Debt / equity | 81.62 |
| Beta vs SPX | 0.17 |
|---|---|
| Corr SPX | 0.10 |
| Annual vol | 28.5% |
| Annual ret | -1.0% |
| Sharpe | -0.03 |
| Max DD | -42.3% |
Window: 504 trading days (504 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.24 | |
| Sector | +0.02 | |
| Technical | +0.18 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $19.02 | $19.28 | $19.02 | $19.20 | 10.40M |
| Aug 12 | $18.69 | $19.06 | $18.65 | $18.98 | 11.03M |
| Aug 11 | $18.90 | $19.10 | $18.88 | $19.05 | 12.78M |
| Aug 10 | $19.03 | $19.16 | $18.89 | $19.03 | 25.55M |
| Aug 7 | $19.08 | $19.27 | $18.86 | $19.23 | 14.33M |